New diabetes clinical trial: Polypill Versus Metformin in New Onset Type 2 Diabetes

Published on: April 27, 2023 at 11:00AM
Condition:   Type 2 Diabetes
Interventions:   Drug: GMRx4 polypill - sitagliptin, dapagliflozin, metformin;   Drug: Metformin
Sponsors:   George Medicines PTY Limited;   MRCF Pty Ltd;   The George Institute
Not yet recruiting
https://ift.tt/aEVwbRn

Comments